Genetics

Diabetes risk impacted more by excess weight than genetics, experts say – Clinical Daily News – McKnight’s Long Term Care News

Excess body weight is a much more powerful risk factor for developing type 2 diabetes than genetics, according to a new study. Bringing weight below an individualized trigger threshold could prevent or even reverse the disease, investigators say.

Data from more than 440,000 adult participants in the UK Biobank study was grouped according to genetic risk of diabetes, and body mass index (a measurement of weight adjusted to height). The group with the highest BMI had 11 times the risk of diabetes compared with participants in the lowest BMI group. The highest BMI group also had a greater likelihood of developing diabetes than all other BMI groups, regardless of genetic risk.

In addition, being overweight for a longer period of time had no effect on risk, the researchers found. This result suggests that when a certain BMI threshold is crossed, the odds of developing diabetes increase and remain high no matter how long an individual is overweight, said Brian Ference, M.D., an epidemiologist from the University of Cambridge, England, and University of Milan, Italy.

The findings indicate that most cases of diabetes could be avoided by keeping BMI below the cut-off which triggers abnormal blood sugar, Ference said. This means that to prevent diabetes, both BMI and blood sugar should be assessed regularly. Efforts to lose weight are critical when a person starts to develop blood sugar problems, he concluded.

The study was presented Monday at the European Society of Cardiology Congress 2020.

Read this article:
Diabetes risk impacted more by excess weight than genetics, experts say - Clinical Daily News - McKnight's Long Term Care News

Genetics

Genetic Testing Services Market: Surge in Adoption of Genetic Testing Services to Boost the Market – BioSpace

Transparency Market Research (TMR) has published a new report titled, Genetic Testing Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20192027.According to the report, the global Genetic Testing Services market was valued at US$ 41.2 Bn in 2018 and is projected to expand at a CAGR of 7.3% from 2019 to 2027.

Overview

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10235

New Born Screening Segment to Dominate Global Genetic Testing Services Market

Request for Analysis of COVID19 Impact on Genetic Testing Services Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=10235

Oncology Segment Hold a Major Share of Global Genetic Testing Services Market

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=10235

Hospitals based laboratories Segment to Dominate Global Genetic Testing Services Market

North America to Dominate Global Genetic Testing Services Market

Buy Genetic Testing Services Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=10235&ltype=S

Competitive Landscape

The global genetic testing services market is consolidated in terms of number of players. Key players in the global Genetic Testing Services market include Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Genomic Health, Inc., NeoGenomics Laboratories, Inc, Eurofins Scientific, Ambry Genetics, Illumina, Inc, 23andMe, Inc., Exact Sciences, Natera, Invitae, Veracyte, and other prominent players.

Browse More Trending Reports by Transparency Market Research:

Nitinol Stents Market: https://www.transparencymarketresearch.com/nitinol-stents-market.html

Neurology Sterile Injectable Market: https://www.transparencymarketresearch.com/neurology-sterile-injectable-market.html

Microplate Systems Market: https://www.transparencymarketresearch.com/microplate-systems-market.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Mr. Rohit BhiseyTransparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

Read this article:
Genetic Testing Services Market: Surge in Adoption of Genetic Testing Services to Boost the Market - BioSpace

Genetics

PREDICTIVE GENETIC TESTING AND CONSUMER/WELLNESS GENOMICS MARKET TRENDS AND DYNAMIC 2025 – Scientect

Predictive Genetic Testing and Consumer/Wellness Genomics Market: Snapshot

Genetic testing comprises examination of ones DNA. The term DNA refers to the chemical database that is responsible for conveying the instructions for functions that need to be performed by the body. Genetic testing is capable of revealing changes or mutations in the genes of living beings, which might result in any kind of disease or illness in the body.

Get Exclusive PDF Sample Copy Of This Report:https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1274

Predictive genetic testingrefers to the utilization of genetic testing methods in an asymptomatic individual to make a prediction about risk of contacting particular disease in future. These tests are regarded as representation of emerging class of medical tests, which differ in fundamental ways from the usual diagnostic tests.

The global predictive genetic testing and consumer/wellness genomics marketis likely to gather momentum owing to the benefits offered by predictive genetic testing.

The benefits of predictive genetic testing are

The global predictive genetic testing and consumer/wellness genomics marketis influenced by reducing cost of genetic sequencing and technological advancement in the field of genetics. North America is expected to emerge as a prominent region for the global predictive genetic testing and consumer/wellness genomics market in years to come due to high adoption rates of latest technologies in all fields.

Over centauries human DNA has undergone tremendous alteration due to evolutionary and lifestyle changes. They have led to both, advantages and disadvantages over the years. Some have given the mankind a deserving edge over other creatures while the others have led to disorders and diseases. Predictive genetic testing and consumer/wellness genomics market thrives on the growing demand for understanding the lineage of a certain gene pool to identify disorders that could manifest in the later or early stage of a human life. The surging demand for understanding the family history or studying the nature of certain diseases has given the global market for predictive genetic testing and consumer/wellness genomics market adequate fodder for growth in the past few years.

This new class of medical tests are aimed at reducing the risk of morbidity and mortality amongst consumers. The thorough surveillance and screening of a certain gene pool can allow an individual to avoid conditions that disrupt normal existence through preventive measures. The clinical utility of these tests remains unassessed. Therefore, increasing research and development by pharmaceutical companies to develop new drugs by understanding diseases and disorders is expected to favor market growth.

Unlike conventional diagnostic testing, predictive genetic testing identifies the risk associated with potential conditions. In certain cases it is also capable of stating when the disease may appear and the how severe will it be. Thus, this form of testing is expected to allow consumers to take up wellness measurements well in time to lead a life of normalcy, characterized by good health.

Buy This Report @https://www.tmrresearch.com/checkout?rep_id=1274<ype=S

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Overview

Predictive genetic testing are used to identify gene mutations pertaining to the disorders that surface at a considerably later stage in life after birth. These tests are particularly beneficial for people from a family with a history of genetic disorder, although they themselves show no symptoms of the disorder at the time of testing. Genetic testing promises to revolutionize the healthcare sector, providing crucial diagnostic details related to diverse verticals such as heart disease, autism, and cancer. As the healthcare sector touches new peaks, the global predictive genetic testing and consumer/wellness genomics market is projected to expand at a healthy growth rate during the forecast period of 2017 to 2025.

This report on the global market for predictive genetic testing and consumer/wellness genomics analyzes all the important factors that may influence the demand in the near future and forecasts the condition of the market until 2025. It has been created using proven research methodologies such as SWOT analysis and Porters five forces. One of the key aspect of the report is the section on company profiles, wherein several leading players have been estimated for their market share and analyzed for their geographical presence, product portfolio, and recent strategic developments such as mergers, acquisitions, and collaborations.

The global predictive genetic testing and consumer/wellness genomics market, on the basis of test type, can be segmented into predictive testing, consumer genomics, and wellness genetics. The segment of predictive testing can be sub-segmented into genetic susceptibility test, predictive diagnostics, and population screening programs, whereas the segment of wellness genetics can be further divided into nutria genetics, skin and metabolism genetics, and others.

By application, the market can be segmented into breast and ovarian cancer screening, cardiovascular screening, diabetic screening and monitoring, colon cancer screening, Parkinsons or Alzheimers disease, urologic screening or prostate cancer screening, orthopedic and musculoskeletal screening, and other cancer screening. Geographically, the report studies the opportunities available in regions such as Asia Pacific, Europe, North America, and the Middle East and Africa.

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Trends and Opportunities

Increasing number of novel partnership models, rapidly decreasing cost of genetic sequencing, and introduction of fragmented point-solutions across the genomics value chain as well as technological advancements in cloud computing and data integration are some of the key factors driving the market. On the other hand, the absence of well-defined regulatory framework, low adoption rate, and ethical concerns regarding the implementation, are expected to hinder the growth rate during the forecast period. Each of these factors have been analyzed in the report and their respective impacts have been anticipated.

Currently, the segment of predictive genetic cardiovascular screening accounts for the maximum demand, and increased investments in the field is expected to maintain it as most lucrative segment. On the other hand, more than 70 companies are currently engaged in nutrigenomics, which is expected to further expand the market.

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Regional Outlook

Owing to robust healthcare infrastructure, prevalence of cardiovascular diseases, and high adoptability rate of new technology makes North America the most lucrative region, with most of the demand coming from the country of the U.S. and Canada. Several U.S. companies hold patents, which further extends the outreach of the market in the region of North America.

Companies mentioned in the research report

23andMe, Inc, BGI, Genesis Genetics, Illumina, Inc, Myriad Genetics, Inc, Pathway Genomics, Color Genomics Inc., and ARUP Laboratories are some of the key companies currently operating in global predictive genetic testing and consumer/wellness genomics market. Various forms of strategic partnerships with operating company and smaller vendors with novel ideas helps these leading players maintain their position in the market.

To know more about the table of contents, you can click @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1274

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to busi-ness entities keen on succeeding in todays supercharged economic climate. Armed with an experi-enced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Read more from the original source:
PREDICTIVE GENETIC TESTING AND CONSUMER/WELLNESS GENOMICS MARKET TRENDS AND DYNAMIC 2025 - Scientect

Genetics

Three Have Tested Positive: Second Testing ‘Imperative’ – Iceland Monitor

Kri Stefnsson, CEO of deCode Genetics. mbl.is/Kristinn Magnsson

Since August 19 , when Iceland began testing all arriving passengers twice for the coronavirus at the border - first upon arrival and then four to five days later - three people have tested positive during the second test, Kri Stefnsson, CEO of deCode Genetics, tells mbl.is .

This is three times as much as we expected, he states. Before these rules were implemented for all arriving passengers, 8,000 Icelanders or residents of Iceland had been subjected to the double screening rule. Among them, we found two who tested positive [the second time], albeit with a large amount of the virus and, therefore, very contagious, Kri explains. Either one of them could have set off a new wave of this pandemic.

The limited experience we have from the second screening suggests it is imperative, he adds. Of course, the experience is very limited, but we must look at this in light of the fact that this virus is setting off a new wave in the countries around us. Its nonsense to assert that it is disappearing and that there is nothing to fear.

Some people have criticized the new rules at the border, calling them too strict, Jn var Einarsson, MD, an Icelandic professor at Harvard Medical School, among them. He believes the rules limit peoples freedom too much and fears that too strict rules may lead to people no longer respecting them.

Kri, on the other hand, states that the rules at the border reduce the likelihood of having to impose strict rules domestically, since the chance of new infections being spread to the country are reduced.

It is important, he states, to focus on what we gain, not just what we lose, through implementing this system. Among the things we gain is that we can operate our schools as usual. There is nothing as important for society than taking good care of children and youth in our schools. The system [of double testing at the border] makes it possible for disease prevention measures not to threaten other industries in the country.

In the long run, he states, it is in the long-term interest of the travel industry to be able to say that we are a nation that takes good care of its people, and people can come here because we are safe here.

According to covid.is , no new domestic case of COVID-19 was confirmed in Iceland yesterday, while two people who tested positive at the border still await the results of an antibody test. At present, there are 100 active cases of the disease in Iceland, and 900 people are in quarantine. The 14-day incidence per 100,000 inhabitants now stands at 24.9, which is lower than it has been in recent days.

Excerpt from:
Three Have Tested Positive: Second Testing 'Imperative' - Iceland Monitor

Genetics

Genetic Counseling Market to Witness an Outstanding Growth During 2020 | AT-GC, Ancestry, Arup Laboratories, Biron Health Group, Color Genomics,…

The Global Genetic Counseling Market provides up-to-date information on current and future industry trends, enabling readers to identify products and services to increase revenue growth and profitability. This research report provides in-depth study of all key factors affecting global and regional markets, including drivers, imprisonment, threats, challenges, opportunities and industry-specific trends. This report cites worldwide trust and specimens with leading players downstream and upstream analysis.

Request Sample Copy of this [emailprotected]: https://www.theresearchinsights.com/request_sample.php?id=255631

This market research report on analyzes the growth prospects for the key vendors operating in this market space including AT-GC, Ancestry, Arup Laboratories, Biron Health Group, Color Genomics, EasyDNA, GenPath Diagnostics (an Opko Health Company), GeneDX (an Opko Health Company), GeneHealth UK, GeneMatters, GeneScreen, Genome Medical, InformedDNA, Invitae Corporation, Laboratory Corporation of America, Metis Genetics, MyOncoPath, Quest Diagnostics Incorporated, Veritas Genetics

Technological advancements in the Genetic Counseling Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period. In addition to the complete assessment of the market, the report presents Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data.

Asia Pacific is the most advanced market for Genetic Counseling. This growth is largely driven by factors such as population perspective improvement and increased awareness. In addition, Latin Americas value-based healthcare services market will expand to a significant CAGR. Brazil and Mexico are leading the value-based health care services market in the region because of the favorable businesses that governments are promoting. Moreover, as research and development develops, market growth in Latin America will accelerate.

Get Reasonable Discount on this Premium Report @: https://www.theresearchinsights.com/ask_for_discount.php?id=255631

Key questions answered in the report include:

This report provides an effective business outlook, different case studies from various top-level industry experts, business owners, and policymakers have been included to get a clear vision about business methodologies to the readers. SWOT and Porters Five model have been used for analyzing the Global Genetic Counseling Market on the basis of strengths, challenges and Global opportunities in front of the businesses.

Enquiry Before [emailprotected] https://www.theresearchinsights.com/enquiry_before_buying.php?id=255631

*If you need anything more than these then let us know and we will prepare the report according to your requirement.

About us:

The Research Insights A global leader in analytics, research and advisory that can assist you to renovate your business and modify your approach. With us, you will learn to take decisions intrepidly. We make sense of drawbacks, opportunities, circumstances, estimations and information using our experienced skills and verified methodologies. Our research reports will give you an exceptional experience of innovative solutions and outcomes. We have effectively steered businesses all over the world with our market research reports and are outstandingly positioned to lead digital transformations. Thus, we craft greater value for clients by presenting advanced opportunities in the global market.

Contact us:

Robin

Sales manager

Contact number: +91-996-067-0000

[emailprotected]

https://www.theresearchinsights.com

Here is the original post:
Genetic Counseling Market to Witness an Outstanding Growth During 2020 | AT-GC, Ancestry, Arup Laboratories, Biron Health Group, Color Genomics,...

Genetics

Animal Genetics Cable Market Analysis with Market Size, Industry Share, trends and Forecast to 2025 – Scientect

Animal Genetics CableMarket Size Covers Global Industry Analysis, Size, Share, CAGR, Trends, Forecast and Business Opportunity.

Download Premium Sample of the Report:https://brandessenceresearch.biz/Request/Sample?ResearchPostId=137&RequestType=Sample

Global Animal Genetics Cable Market Size Study by End-Use Industry (Building & Construction, Automotive & Transportation, Manufacturing, Energy) By Insulation Material (XPLE, LSZH, PVC, EPR) and Regional Forecasts 2017-2025.Global Animal Genetics Cable Market to reach USD 8.7 billion by 2025.

Global Animal Genetics Cable Market valued approximately USD 3.62 billion in 2016 is anticipated to grow with a healthy growth rate of more than 10.30% over the forecast period 2017-2025. The driving force for the growth of the Animal Genetics Cable Market is that this market is mainly driven by increasing animal protein consumption, rising adoption of advanced genetic technologies for larger-scale production and quality breeds, as well as development for cutting-edge technologies in animal genetic testing.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

oBy TypeAnimal Genetic ProductsoLive AnimalsoPoultryoPorcineoBovineoCanineoGenetic MaterialsoSemenoBovineoPorcineoCanineoEquineoEmbryooBovineoEquineoAnimal Testing ServicesoDNA TypingoGenetic Trait TestsoGenetic Disease TestsBy Regions:oNorth AmericaoU.S.oCanadaoEuropeoUKoGermanyoAsia PacificoChinaoIndiaoJapanoRest of the World

Furthermore, years considered for the study are as follows:

Historical year 2015Base year 2016Forecast period 2017 to 2025

Some of the key manufacturers involved in the market are Genus Plc (U.K.), Topigs (Netherlands), Envigo (U.S.), CRV Holding B.V. (Netherlands), Hendrix Genetics BV (Netherlands), Groupe Grimaud (France), Neogen Corporation (U.S.), Alta Genetics (Canada), VetGen (U.S.), Zoetis, Inc. (U.S.), and Animal Genetics, Inc. (U.S.). Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Animal Genetics Cable in Market Study:

oKey Consulting Companies & AdvisorsoLarge, medium-sized, and small enterprisesoVenture capitalistsoValue-Added Resellers (VARs)oThird-party knowledge providersoInvestment bankersoInvestors

Key factors influencing market growth:

Request Customization of the Report: https://brandessenceresearch.biz/Request/Sample?ResearchPostId=137&RequestType=Methodology

Customization of the Report:

Brandessence Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

To summarize, the Animal Genetics Cable market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students.

Top Trending Reports:

https://www.marketwatch.com/press-release/blood-bank-information-system-market-size-2020-to-show-impressive-growth-by-2025-industry-trends-share-top-key-players-analysis-and-forecast-research-2020-08-12?tesla=y

https://www.marketwatch.com/press-release/us-orthopedics-medical-imaging-market-size-research-study-including-growth-factors-market-dynamics-and-forecast-to-2025-2020-08-12?tesla=y

https://www.marketwatch.com/press-release/vascular-access-device-market-size-2020-share-demand-types-top-key-players-and-forecast-to-2025-2020-08-12?tesla=y

https://www.pharmiweb.com/press-release/2020-08-12/nuclear-medicine-market-size-2020-growing-demand-analysis-industry-growth-regional-revenue-top

https://www.pharmiweb.com/press-release/2020-08-12/dengue-testing-market-size-2020-global-share-industry-analysis-technology-trends-top-leaders-gr

View original post here:
Animal Genetics Cable Market Analysis with Market Size, Industry Share, trends and Forecast to 2025 - Scientect

Embryology

Los Angeles fertility expert Dr. Mark Surrey Partners with the Exclusive Haute MD – PR Web

"Dr. Surrey is able to offer a broad range of advanced treatments, including: in vitro fertilization, embryology and embryo scope evaluations"

LOS ANGELES (PRWEB) August 28, 2020

Dr. Mark Surrey has been in practice for over 25 years. He is a board-certified reproductive and endoscopic surgeon and serves as a clinical professor in the Department of OBGYN at UCLAs David Geffen School of Medicine.

He was elected President of the American Laparoscopy Society & Pacific Coast Reproductive Society and is a Clinical Director of Fellowship Training for UCLA & Cedars Sinai Reproductive Endocrinology. Also a founding member of The Society of Reproductive Surgeons. He is the associate director at the Southern California Reproductive Center, a clinic he co-founded.

Dr. Surrey is able to offer a broad range of advanced treatments, including: in vitro fertilization, embryology and embryo scope evaluations for an increased pregnancy success rate, pre-implementation genetic diagnosis to decrease anomalies and miscarriages in older patients, surrogacy and egg/sperm freezing.

Visit Dr. Mark Surrey's Haute MD Profile at: https://hauteliving.com/hautebeauty/mdmember/dr-mark-surrey/

Visit Dr. Mark Surrey's website at: https://www.scrcivf.com/doctors/mark-w-surrey/

ABOUT HAUTE MD:

Haute MD offers readers access to an invite-only, prominent collective of leading doctors and industry-leading surgeons located in their area. Haute MD is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute MD covers the latest advancements in beauty and wellness, providing readers with expert advice on medical treatments through its network of acclaimed surgeons and doctors.

To learn more about Haute MD, visit h https://hauteliving.com/hautebeauty/mdmember/

Share article on social media or email:

See original here:
Los Angeles fertility expert Dr. Mark Surrey Partners with the Exclusive Haute MD - PR Web

Embryology

Mask, hand washing and stress cause an increase in dermatological consultations – Explica

He Massive and constant use of a mask to avoid the spread of Covid-19 has had an impact on the health of the skin of many people. With the arrival of the pandemic, dermatologists have seen a progressive increase in patients who come to consultations for skin problems, said the Dr. Franco Gemigniani, a dermatologist at the new Cordillera Clinic.

He prolonged use of the mask is one of the reasons for this increase. The constant pressure that clogs the pores, moisture and heat concentrated under the area of the mask can cause breakouts of acne and rosaceaThe specialist clarified, adding that around half of the patients he has seen during the pandemic are due to aggravation of pimples or pimples.

Since it is impossible to think about stopping using a mask, the expert recommended having appropriate care routines for your skin type. In the case of oily or acneic skin, I recommend the use of cleansing gels, mattifying creams and creams with a peeling effect for this type of skin.

Meanwhile, for cases of rosacea, the advice is use micellar waters for cleaning, because soaps can be very aggressive and cause irritation, in addition to anti-redness creams. In severe cases, the use of oral antibiotics or medicated creams is necessary, for the control of these pathologies.

The doctor indicated that other factors related to the pandemic and that have an incidence in the greater number of dermatological consultations are the high level of stress derived from prolonged confinement and the uncertainty generated by the situation. The skin is the reflection of our state of mind, and this is explained from embryology. Both the skin and our nervous system come from the ectoderm, which is one of the 3 germ layers of the embryo. There is an important connection between our nervous system, the skin and its annexes; as are the hair and nails. Skin diseases such as seborrheic dermatitis or psoriasis present outbreaks of deterioration in times of stress .

Also, the constant hand washing and the use of alcohol gel, one of the most effective measures for infection control, It can cause extreme dryness in the hands, with flaking, even leading to cracking, redness and burning. This is a fairly common condition today, which we call irritant contact dermatitis of the hands. The basis of the treatment is the constant use of moisturizing or emollient hand creams hopefully neutral without perfumes or other possible sensitizers. Severe symptoms require the use of corticosteroid creams and special creams for the treatment of fissures , explained the dermatologist.

Here is the original post:
Mask, hand washing and stress cause an increase in dermatological consultations - Explica

Embryology

Global in vitro fertilization (IVF) market size was USD 16.89 billion in 2018 and is projected to reach USD 36.39 billion by 2026, exhibiting a CAGR…

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the In Vitro Fertilization (IVF) market.

Trusted Business Insights presents an updated and Latest Study on In Vitro Fertilization (IVF) Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the In Vitro Fertilization (IVF) market during the forecast period (2019-2029).It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ In Vitro Fertilization (IVF) Market Size, Share & Industry Analysis, By Type (Conventional IVF, and IVF with ICSI), By Procedure (Fresh Non-donor, Frozen Non-donor, Fresh Donor, and Frozen Donor), By End User (Hospitals, and Fertility Clinics) and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

The global in vitro fertilization (IVF) market size was USD 16.89 billion in 2018 and is projected to reach USD 36.39 billion by 2026, exhibiting a CAGR of 10.1% during the forecast period.

We have updated In Vitro Fertilization (IVF) Market with respect to COVID-19 Impact.Inquire before buying

In vitro fertilization (IVF) is one of the most widely used assisted reproductive technology (ART) and it works by using the combination of both medicines and surgical procedures. The IVF treatment helps with embryo development, and implantation in an infertile couple. IVF is the process of fertilization by extracting eggs, retrieving a sperm sample and then manually combining egg and sperm in a laboratory. Growing adoption of IVF technique has resulted in ever year around half a million babies born using IVF or other assisted reproductive techniques. Thus, growing popularity of IVF & ICSI treatment is anticipated to boost the adoption of in vitro fertilization (IVF) treatment during the forecast period.Rising prevalence of infertility, increasing success rate of IVF procedures and increasing awareness about infertility are some of the major factors fueling the demand for IVF treatment worldwide. Moreover, the introduction of advanced and extended fertility treatment of IVF i.e. intracytoplasmic sperm injection (ICSI) is expected to drive the growth of in vitro fertilization (IVF) market during 2019-2026 period.

However, the high cost and risks associated with IVF and ICSI treatment are some factors restraining the IVF market growth during the forecast period. For instance, according to a data published by the Reproductive Science Center, a rare condition called Imprinting Disorders was associated with some IVF procedures and it was estimated that the risk of such disorders with IVF treatment was around 2 to 5 per 15,000 births using IVF technique, while the risk in general cases was 1 in 15,000 normal births. Hence, such potential risks and birth defects associated with IVF treatment can hamper the adoption of IVF or ICSI procedure worldwide.

MARKET DRIVERS

Delay in Pregnancies is Accelerating Demand for IVF TreatmentIt is observed that in females, the chances of conceiving start to reduce after the age of 32 and it drop by half by the age of 40. In many countries, a drastic increase in median age of women for first time pregnancy is observed which is leading to several complications associated with pregnancy and also increases the risk of infertility in female partners. Some of the major reasons attributed to the delay in pregnancy are late marriages, couples prioritizing their careers over family planning, and financial instability, etc. Thus, the increasing trend of delaying pregnancy is resulting in infertility that is subsequently increasing the adoption rate of IVF treatment on a global basis. For instance, it has been estimated by various studies that the average fertility rate of the world has declined by 2.5% and the major reason responsible for this is delayed pregnancies in women.

Globally Increasing Prevalence of Infertility is Boosting the Adoption of IVFThe rising prevalence of infertility in countries such as China, U.S, UK and Japan is expected to fuel the demand for in vitro fertilization (IVF) treatment during the forecast period. For instance, according to a data published by the National Survey of Family Growth (NSFG) in 2018, around 6.7% of women in the U.S, aged between 15 to 44 years were suffering from infertility. Also, increasing prevalence of male infertility in the world is anticipated to fuel the adoption of IVF ICSI treatment. For instance, according to a data published by NCBI, it was stated that in 2015, nearly 15.0% of couples present in the world were affected by infertility and among them, the male partners were solely responsible for almost 20.0% -30.0% of the cases. Along with this, shift towards sedentary lifestyle, rising stress level and obesity among the general population are some of the other factors responsible for an increasing prevalence of infertility. Thus, is expected to promote the IVF treatment market growth worldwide. Additionally, governments of some countries are taking initiatives to provide better reimbursement policies for IVF procedures. Hence, these initiatives are anticipated to attract high in vitro fertilization market revenue during the forecast period.SEGMENTATION

By Type Outlook

VF with ICSI Segment is Expected to Dominate the IVF MarketOn the basis of types, the in IVF market segments include conventional IVF, and IVF with ICSI. The IVF with ICSI segment dominated the market in 2018 owing to the increasing number of IVF-ICSI procedures worldwide. For instance, according to the Family Fertility Center, it was estimated that in 2018, IVF-ICSI procedures accounted for approximately 75.0% of all IVF procedures performed in the U.S. It is also observed that the intracytoplasmic sperm injection (ICSI) is a preferred choice of treatment for male infertility. Thus, the introduction of such advanced technologies like ICSI coupled with the increasing prevalence of male infertility cases are projected to boost the growth of this segment during the forecast period.

Similarly, the conventional IVF segment is expected to grow at a significant pace during the 2019-2026 period. This growth is attributed to the rising shift of infertile couples towards standard IVF treatment as it involves a comparatively lower risk than the ICSI procedure. Also, it is proved by various studies that the success rate of conventional IVF and IVF along with ICSI are same in couples where the female partner is suffering from infertility. Hence, such data is anticipated to increase the growth rate of this segment by the end of 2026.

By Procedure Outlook

Fresh Non-donor Segment to Hold a Dominant Share in 2018Based on procedure, the global market is segmented into fresh non-donor, frozen non-donor, fresh donor and frozen donor. The fresh non-donor segment is anticipated to register a high CAGR during the forecast period primarily due to the rising prevalence of infertility combined with high success rate of IVF procedures using fresh eggs or embryos. For instance, as per a study published in the Oxford journal, 2017, out of all fertility cycles performed in U.K, an estimated 19.0% would result in live birth if the egg used for the process had never been frozen.

However, the frozen-non donor segment holds the second position in the procedure segment owing to its low cost than the IVF cycles using fresh eggs or embryos. Similarly, the fresh donor and frozen donor segments are expected to register a comparatively moderate CAGR during the forecast period owing to the stringent government regulations in many countries regarding egg & sperm donation.

By End User Outlook

Fertility Clinics Dominate the End User Segment in 2018In terms of end user, the global IVF market is segmented into fertility clinics and hospitals. The fertility clinics segment is expected to dominate the market during the forecast period. This dominance is attributed to the increasing number of IVF procedures in fertility clinics, coupled with presence of specialized staff that provide accurate care to the patients. Furthermore, the in vitro fertilization market share from fertility clinics segment is anticipated to grow at a faster pace owing to increasing number of registered fertility clinics in developed and emerging countries such as China, Japan and Brazil.

The hospitals segment accounted for a comparatively lower share of the global market in 2018. The slow growth of this segment is attributed to fewer number of patient visits in hospitals for treatment of infertility, lack of expertise for IVF in hospital settings, and inadequate reimbursement policies in these settings.

REGIONAL ANALYSIS

Europe generated a revenue of USD 7.57 billion in 2018 and dominated the vitro fertilization market share in 2018. The dominance is attributed to increasing prevalence of infertility, coupled with the rising success rate of IVF treatment in the region. European countries such as Spain and Denmark are considered to be the most active nations for IVF treatment and are responsible to drive the market growth of this region during 2019-2026 period. For instance, according to a data published by European Society of Human Reproduction and Embryology (ESHRE) states that the pregnancy rate per treatment in Europe in 2016 was around 30.5% which witnessed a growth of 1.3% than the previous year owing to high success rate of IVF & ICSI procedures. Thus, the increasing birth rate from IVF and ICSI procedures in Europe is anticipated to boost the adoption of IVF in this region during the forecast period.Europe In Vitro Fertilization (IVF) Market Size, 2018

However, North America is projected to register a steady growth during the forecast period owing to comparatively high cost of IVF and ICSI treatment in this region. For instance, according to FertilityIQ database 2017, a patient spends around US$ 22,000.0 for a single IVF cycle in the U.S. Hence, the increasing IVF cost coupled with growing demand in U.S is resulting in patients travelling to other countries for the treatment. Thus, such trend is leading to a steady growth of this region during forecast period.

Asia Pacific is anticipated to project a higher CAGR by the end of 2026 due to the increasing awareness regarding infertility, coupled with the rise in medical tourism in this region. Additionally, an increase in number of registered fertility clinics is observed in the region which is further expected to result in higher adoption of IVF treatment during the forecast period. For instance, according to the Fertility Society of Australia, in 2018 there were around 120 registered clinics present in Australia, among which almost 98.0% were providing IVF services. Moreover, Latin America and Middle East & Africa are expected to hold considerable IVF market shares owing to their developing health care infrastructure which is subsequently increasing medical tourism in these regions for infertility treatment.

INDUSTRY KEY PLAYERS

Monash IVF, Pelargos IVF and Boston IVF, are Among Major Players Providing IVF TreatmentMonash IVF, Boston IVF and Pelargos IVF are some of the leading service providers of in vitro fertilization market. These companies offer IVF & ICSI treatment with comprehensive care provided by their highly qualified physicians and nursing staff which are primarily responsible for their popularity in the global market. On the other hand, companies like Bloom IVF Centre and Bangkok IVF center are focused in offering IVF treatment at a comparatively lower price that is subsequently up surging medical tourism in their clinics. Other treatment providers engaged in in vitro fertilization (IVF) market are Ovation Fertility, CMRE, Shady Grove Fertility and Group Ambroise Par Clinic.

LIST OF KEY COMPANIES COVERED:

REPORT COVERAGE

The report presents a comprehensive assessment of the global in vitro fertilization (IVF) market by offering valuable insights, facts, industry-related information, and historical data. Several methodologies and approaches are adopted to make meaningful assumptions and views. Furthermore, the report offers a detailed analysis and information as per market segments, helping our readers to get a comprehensive overview of the global IVF market.

Report Scope & Segmentation

Segmentation

By Type

By Procedure

By End User

By Geography

INDUSTRY DEVELOPMENT:

July 2019: Shady Grove Fertility announced the opening of its new full service in vitro fertilization (IVF) center in Tampa, Florida

May 2019: Scientist of Monash IVF developed a new embryo screening test in order to reduce risk of miscarriage during IVF treatment

May 2019: NMC Health plc, acquired a majority of stake in Boston IVF with an aim to create the most diversified and experienced fertility network in the world.

Looking for more? Check out our repository for all available reports on In Vitro Fertilization (IVF) in related sectors.

Quick Read Table of Contents of this Report @ In Vitro Fertilization (IVF) Market Size, Share & Industry Analysis, By Type (Conventional IVF, and IVF with ICSI), By Procedure (Fresh Non-donor, Frozen Non-donor, Fresh Donor, and Frozen Donor), By End User (Hospitals, and Fertility Clinics) and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

Trusted Business InsightsShelly ArnoldMedia & Marketing ExecutiveEmail Me For Any ClarificationsConnect on LinkedInClick to follow Trusted Business Insights LinkedIn for Market Data and Updates.US: +1 646 568 9797UK: +44 330 808 0580

Visit link:
Global in vitro fertilization (IVF) market size was USD 16.89 billion in 2018 and is projected to reach USD 36.39 billion by 2026, exhibiting a CAGR...

Immunology

UConn Health, CaroGen Collaborate on Promising Technology for Colorectal Cancer Treatment – UConn Today

Researchers at UConn Health and CaroGen Corporation, a biopharmaceutical company based at UConns Technology Incubation Program (TIP) facility in Farmington, have developed a promising clinical candidate for colorectal cancer treatment.

Kepeng Wang, assistant professor of immunology at UConn Health and a member of CaroGens Scientific Advisory Board, identified CARG-2020 as an oncolytic vector a virus that infects and kills cancer cells with the capacity to impact three critical cancer pathways.

Using CaroGens patented Artificial Virus for Infectious Diseases and Immune-Oncology (AVIDIO) platform, CARG-2020 targets three pathways by releasing an RNA expressing three immuno-modulators, each formulated to modify one of three pathways.

The novel benefit of CARG-2020 is that it can attack all three pathways at once. Scientists have previously had limited successes targeting these pathways individually.

They each carry out a unique function, Wang says. We think this combination approach will be the strongest immunology against cancer.

The first pathway, IL-17, promotes tumor growth and impedes the recruitment of anti-cancer Tcells. IL-12 is a cancer-fighting pathway normally shut down in tumors. It supports the development of Tcells. The PD-1 pathway also supports tumor growth by binding to Tcells and making these cells less active against tumors.

According to initial data, this approach is proving effective at not only regressing solid tumors, but preventing their regrowth.

Its really groundbreaking, Bijan Almassian, chief executive officer and co-founder of CaroGen, says. We hope to expand this collaboration and go beyond colorectal cancer.

The AVIDIO platform, developed by Yale University School of Medicine professor John Rose more than a decade ago, was licensed to CaroGen in 2012. The diverse platform has many applications in the treatment and prevention of cancer and infectious diseases.

CARG-2020 is also being tested in other solid tumors including ovarian and liver cancer. In addition, CaroGen is working with scientists from Yale to develop a COVID-19 vaccine using AVIDIO.

Wangs lab has been working with CaroGen since 2016 when professor and chair of immunology at UConn Health, Anthony Vella, introduced them.

We work very well together and Im very proud to be part of that, Wang says.

This collaboration outlines a fruitful business model in which research labs and corporations support one anothers missions for the overall advancement of science.

UConn Health is a source of a lot of innovation and great science, and collaboration is easy, given our location at UConns business incubator, the Technology Incubation Program (TIP), Almassian says.

The next steps for CARG-2020 are to seek funding to bring it into a clinical trial setting.

Its been extremely productive and efficient, Almassian says. Were addressing a major unmet medical need.

Wang holds a Ph.D. in biochemistry from the Hong Kong University of Science and Technology. His research focuses on the role of interleukin-17 (IL-17) family cytokines in colorectal cancer development and therapeutic intervention.

Follow UConn Research on Twitter & LinkedIn.

Read this article:
UConn Health, CaroGen Collaborate on Promising Technology for Colorectal Cancer Treatment - UConn Today